Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$123.43
+0.8%		$120.10
$100.85
▼
$212.00
$4.04B1.31661,738 shs430,057 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$125.53
+0.2%		$110.33
$62.00
▼
$126.14
$4.26B0.62865,648 shs653,521 shs
LivaNova PLC stock logo
LIVN
LivaNova
$81.20
-1.5%		$80.72
$48.82
▼
$85.76
$4.54B0.87630,276 shs694,082 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$23.58
+2.0%		$25.17
$15.59
▼
$35.87
$1.16B1.21844,300 shs798,351 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
+0.77%+6.10%-2.91%+14.17%-30.10%
Integer Holdings Corporation stock logo
ITGR
Integer
+0.17%+0.17%+0.47%+36.28%+18.72%
LivaNova PLC stock logo
LIVN
LivaNova
-1.46%+1.46%-4.83%+12.22%+43.49%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
+2.03%+5.31%-2.24%-21.37%-13.69%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$123.43
+0.8%		$120.10
$100.85
▼
$212.00
$4.04B1.31661,738 shs430,057 shs
Integer Holdings Corporation stock logo
ITGR
Integer
$125.53
+0.2%		$110.33
$62.00
▼
$126.14
$4.26B0.62865,648 shs653,521 shs
LivaNova PLC stock logo
LIVN
LivaNova
$81.20
-1.5%		$80.72
$48.82
▼
$85.76
$4.54B0.87630,276 shs694,082 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$23.58
+2.0%		$25.17
$15.59
▼
$35.87
$1.16B1.21844,300 shs798,351 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
+0.77%+6.10%-2.91%+14.17%-30.10%
Integer Holdings Corporation stock logo
ITGR
Integer
+0.17%+0.17%+0.47%+36.28%+18.72%
LivaNova PLC stock logo
LIVN
LivaNova
-1.46%+1.46%-4.83%+12.22%+43.49%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
+2.03%+5.31%-2.24%-21.37%-13.69%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.94
Moderate Buy$179.9345.77% Upside
Integer Holdings Corporation stock logo
ITGR
Integer
2.07
Hold$109.86-12.49% Downside
LivaNova PLC stock logo
LIVN
LivaNova
2.55
Moderate Buy$84.133.60% Upside
STAAR Surgical Company stock logo
STAA
STAAR Surgical
1.92
Reduce$28.4020.44% Upside

Current Analyst Ratings Breakdown

Latest STAA, LIVN, ITGR, and IRTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2026
LivaNova PLC stock logo
LIVN
LivaNova
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$87.00 ➝ $90.00
9/2/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/19/2026
LivaNova PLC stock logo
LIVN
LivaNova
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/18/2026
LivaNova PLC stock logo
LIVN
LivaNova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C) ➝ Hold (C+)
8/18/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$180.00 ➝ $168.00
8/17/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$28.00
8/17/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetHold$31.00 ➝ $28.00
8/13/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$28.00
8/13/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D-) ➝ Sell (D+)
8/13/2026
Integer Holdings Corporation stock logo
ITGR
Integer
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
8/13/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$33.00
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$747.14M5.45N/AN/A$5.64 per share21.88
Integer Holdings Corporation stock logo
ITGR
Integer
$1.85B2.30$10.38 per share12.09$50.56 per share2.48
LivaNova PLC stock logo
LIVN
LivaNova
$1.39B3.22$4.77 per share17.04$24.06 per share3.37
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$239.44M4.94N/AN/A$7.29 per share3.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$44.55M-$0.43N/A85.12N/A-1.69%10.11%1.53%10/29/2026 (Estimated)
Integer Holdings Corporation stock logo
ITGR
Integer
$102.81M$3.6634.3018.682.366.97%12.79%6.48%10/22/2026 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$3.3824.0219.61N/A12.82%16.35%7.76%11/4/2026 (Estimated)
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-$80.45M$0.07336.9143.67N/A1.13%9.05%6.99%11/4/2026 (Estimated)

Latest STAA, LIVN, ITGR, and IRTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$0.2214$0.39+$0.1686$0.39$90.60 million$93.54 million
8/6/2026Q2 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.04$0.58+$0.62-$0.01$219.30 million$224.17 million
8/6/2026Q2 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.09$1.26+$0.17$1.93$380.50 million$390.59 million
8/3/2026Q2 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.38$1.60+$0.22$0.69$451.07 million$464.11 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
3.50
3.86
3.74
Integer Holdings Corporation stock logo
ITGR
Integer
0.75
3.73
2.41
LivaNova PLC stock logo
LIVN
LivaNova
0.22
1.45
1.21
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/A
4.66
4.03

Institutional Ownership

CompanyInstitutional Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.98%
Integer Holdings Corporation stock logo
ITGR
Integer
1.10%
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
39.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,40032.96 million32.64 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00033.99 million33.62 millionOptionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30055.09 million54.90 millionOptionable
STAAR Surgical Company stock logo
STAA
STAAR Surgical
1,21150.14 million30.14 millionOptionable

Recent News About These Companies

Zacks Research Downgrades STAAR Surgical (NASDAQ:STAA) to Hold
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-zacks-research-downgrades-staar-surgical-nasdaq-staa-to-hold-2026-09-04/
Bank of New York Mellon Corp Invests $6.58 Million in STAAR Surgical Company $STAA
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-invests-658-million-in-staar-surgical-company-staa-2026-09-04/
STAAR Surgical Appoints Ben Park as Chief Technology Officer
September 2 at 11:10 PM  |  marketscreener.comM
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer
September 2 at 11:10 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/staar-surgical-names-medtech-innovator-200100168.html
STAAR Surgical (NASDAQ:STAA) Trading Up 5.4% - Here's What Happened
September 1 at 1:39 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-staar-surgical-nasdaq-staa-trading-up-54-heres-what-happened-2026-09-01/
STAAR Surgical Company (NASDAQ:STAA) Receives Average Rating of "Hold" from Brokerages
August 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30989736
STAAR Surgical Company (NASDAQ:STAA) Receives Consensus Rating of "Hold" from Brokerages
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-staar-surgical-company-nasdaq-staa-receives-consensus-rating-of-hold-from-brokerages-2026-08-29/
Staar Surgical Targets Presbyopia Growth With New Trifocal ICL Trial
August 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/staar-surgical-targets-presbyopia-growth-with-new-trifocal-icl-trial?utm_source=marketbeat.com&utm_medium=referral
Staar Surgical Advances Next‑Gen ICL Study, Signaling Long‑Term Growth Potential
August 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/staar-surgical-advances-nextgen-icl-study-signaling-longterm-growth-potential?utm_source=marketbeat.com&utm_medium=referral
American Capital Management Inc. Makes New $24.29 Million Investment in STAAR Surgical Company $STAA
August 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-american-capital-management-inc-makes-new-2429-million-investment-in-staar-surgical-company-staa-2026-08-27/
5 insightful analyst questions from STAAR Surgical’s Q2 earnings call
August 20, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/5-insightful-analyst-questions-from-staar-surgical-s-q2-earnings-call/ar-AA2asi4b
Why STAAR Surgical (STAA) shares are sliding today
August 17, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/why-staar-surgical-staa-shares-are-sliding-today/ar-AA2ajyu1
Why STAAR Surgical (STAA) Is Up 8.1% After Q2 Profit Rebound And New CEO Appointment
August 17, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/why-staar-surgical-staa-8-190804380.html
STAAR Surgical (NASDAQ:STAA) Shares Down 6.6% Following Analyst Downgrade
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/staar-surgical-nasdaqstaa-shares-down-66-following-analyst-downgrade-2026-08-17/
Deciphering Staar Surgical (STAA) International Revenue Trends
August 17, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2975548/deciphering-staar-surgical-staa-international-revenue-trends?cid=cs-stocknewsapi-ft-fundamental_analysis|nfm_international_revenues-2975548
Stifel Nicolaus Lowers STAAR Surgical (NASDAQ:STAA) Price Target to $28.00
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/stifel-nicolaus-lowers-staar-surgical-nasdaqstaa-price-target-to-2800-2026-08-17/
Quantinno Capital Management LP Takes $1.11 Million Position in STAAR Surgical Company $STAA
August 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-quantinno-capital-management-lp-takes-111-million-position-in-staar-surgical-company-staa-2026-08-16/
Staar Surgical Co (STAA) Shares Surge 3.4% -- What GF Score of 80 Tells Investors
August 14, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9035959/staar-surgical-co-staa-shares-surge-34-what-gf-score-of-80-tells-investors
STAA Q2 deep dive: China demand and product expansion drive revenue growth amid market caution
August 14, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/staa-q2-deep-dive-china-demand-and-product-expansion-drive-revenue-growth-amid-market-caution/ar-AA2a6PVg
Clarification: Earns-Staar Surgical story
August 14, 2026  |  chron.comhttps://www.chron.com/business/article/staar-surgical-q2-earnings-snapshot-22385694.php
Clarification: Earns-Staar Surgical story
August 14, 2026  |  chron.comhttps://www.chron.com/business/article/staar-surgical-q2-earnings-snapshot-22385694.php

New MarketBeat Followers Over Time

Media Sentiment Over Time

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$123.43 +0.94 (+0.77%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$123.00 -0.43 (-0.35%)
As of 06:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Integer stock logo

Integer NYSE:ITGR

$125.53 +0.22 (+0.18%)
Closing price 09/3/2026 03:58 PM Eastern
Extended Trading
$125.70 +0.17 (+0.14%)
As of 07:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$81.20 -1.20 (-1.46%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$81.40 +0.20 (+0.25%)
As of 04:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

STAAR Surgical stock logo

STAAR Surgical NASDAQ:STAA

$23.58 +0.47 (+2.03%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$23.58 0.00 (-0.02%)
As of 05:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas